2013 FDA Approval
After an extensive on-site review, the FDA has determined that GRAM meets all requirements for production of parenteral drug products, both aseptically filled and terminally sterilized.
The Latest From Grand River Aseptic Manufacturing
News
Harnessing the Power of CDMOs in Modern Drug Development
Change is constant in the pharmaceutical industry, and companies must keep pace with regulatory requirements, technological advancements, and patient expectations....
News
Executives from GRAM and LTS Discuss Qualities of a CDMO Redefining Innovation
What are the traits that redefine innovation in fill-finish partners? GRAM’s CEO and LTS device leadership come together to discuss...
News
Embracing a Proactive Approach: What it Takes to Offer Patient-Centric CDMO Solutions
In today’s world, where customization is essential, patients have a growing expectation for accessible and comfortable medication. We are witnessing...